Real-World Data on Treatment Choices for mccRCC
Caring for HER2+ mBC Patients Through Collaboration and Communication
Jennifer Caudle, DO
Megan Kruse, MD
Marcela Mazo Canola, MD
Revolutionizing Oncology: The Promising Role of AI in Cancer Care
HER2+ Metastatic Breast Cancer Therapies: Managing Adverse Events
Pavani Chalasani, MD, MPH
Radiopharmaceuticals: A Revolution in Modern Medicine
Unveiling the Future: Can't Miss Opportunities at SNMMI 2024
WHIM Syndrome: A Chronic Neutropenic Disorder
Peter E. Newburger, MD
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
WHIM Syndrome Treatment: We Can Do Better!
Jolan Walter, MD, PHD
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
Teresa K. Tarrant, MD
WHIM Syndrome: A Misguided Immune System!
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
Jacob R. Bledsoe, MD
WHIM Syndrome (A Chronic Neutropenic Disorder): Uncouple the Complex for HCPs and Patients
WHIM Syndrome Management: The First FDA Approval for Patients
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity
Brian P. McDonough, MD, FAAFP
Frank Diehl, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.